We have the science, the technology, the medical need — and now the regulatory momentum — to deliver on the global promise of gene editing on demand
https://t.co/x1A91DPa3M
Just Published - Read about how orthobiologics and cellular therapies are evolving at a rapid pace and how you can utilize this as an Physical Medicine provider. #physicalmedicine#mayoclinic
The ISSCR, @CIRMnews, and @UCLAstemcell have just kicked off the Summit on Access and Affordability in Cell and Gene Therapies! Global leaders have convened to tackle how to make cell and gene therapies more accessible to patients worldwide.
Join us on 20 March in Los Angeles for the ISSCR Summit on Access and Affordability in Cell and Gene Therapies, where global leaders will discuss critical challenges for emerging therapies. Learn more 👉 https://t.co/WrkqBm3G4F
Japan becomes the first country to approve iPSC-based medicinal products - two in fact - a historic moment nearly 20 years since the discovery of #iPSCs! One for cardiac regeneration, and one for Parkinson's.
https://t.co/IQJ1zhXwEM
Dr. Carmen Terzic knows about being a female leader -- she is a staff consultant and scientist at our Rochester, MN campus, and served as the Chair of PM&R from 2011-2020. Come learn from her expertise tomorrow 🗓️ Feb 20 ⏰ 3:30 pm
#womeninmedicine@AAPhysiatrists
Cancer Statistics 2026 are out!
✅“The cancer mortality rate continued to decline through 2023, averting 4.8 million deaths since 1991, largely because of smoking reductions, earlier detection, and improved treatment.”
⚠️5-yr overall survival is 35% for patients with metastatic disease. Still
Some work to do
⛔️“decades of scientific investment have translated to longer lives for people with even the most fatal cancers. However, continued progress is threatened by proposed federal cuts to cancer research and health insurance, which provides access to life-saving cancer treatment”
https://t.co/lZOXobGVMH
Dr. Clay Smither, Chair of Physical Medicine and Rehabilitation at the Mayo Clinic, will be sharing about his leadership journey and key principles to becoming a leader of both your patients and colleagues, specifically in the context of PM&R.
Sign up at the link in our bio!
A landmark moment for the rare disease community: The @FDA has approved Waskyra, the first gene therapy for #WiskottAldrichSyndrome and the first-ever #GeneTherapy to be brought through regulatory approval by a nonprofit organization, demonstrating a vital new pathway for ultra-rare disease treatments.
Read more from ASGCT President Terry Flotte, MD, on the clinical impact and the importance of nonprofit research: https://t.co/VI4M0OFjZG
🏈NY Giants team doctor & @ISCTglobal member: Clinics offering ‘miracle injections,’ ‘next generation cell therapies’ are selling false hope - We must separate the science from the sales pitch in regenerative medicine. @statnews https://t.co/00Ee7DxENA
Enjoyed learning about orthobiologics versus cellular therapies from Dr. Shannon Strader. I appreciated her clear breakdown of the complex science behind cell-based treatments. Excited for the developments in this field! Thank you to @aocpmr for hosting this event! @ShanStraderDO
Be sure to tune in to this member-exclusive webinar Dec 4 so you can listen to Dr. Strader about cell & gene therapy! https://t.co/o2Lf8D5A2i #regenerativemedicine#genetherapy#ISCT
Join us for a discussion lead by Dr. Shannon Strader, a Cellular Therapy Fellow at the Mayo Clinic, on December 9th at 7 pm EST as we break down treatment options, training pathways, and emerging technologies in the field. Don’t miss it!
https://t.co/REjqToaLyO.